25 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 25 of 25 clinical reviews.
Evidence-based analysis of the 5-HTP and MOTS-c interaction profile, covering serotonin syndrome risk, pharmacodynamic overlap, dose-separation strategy, and monitoring recommendations.
A guide to combining alpha-lipoic acid with the MOTS-c mitochondrial peptide, covering pharmacodynamic interactions, hypoglycemia risk, thyroid effects, dosing windows, and monitoring protocols.
A guide to combining ashwagandha with the MOTS-c mitochondrial peptide: mechanisms, potential pharmacodynamic interactions, monitoring, and practical dosing guidance.
Evidence-based review of the berberine and MOTS-c interaction, covering AMPK overlap, CYP3A4 inhibition, dose-separation strategies, and clinical monitoring for patients using both compounds.
A guide to combining caffeine with MOTS-c mitochondrial peptide: pharmacokinetic and pharmacodynamic interactions, glucose effects, blood pressure risks, dose-separation windows, and monitoring protocols.
A guide to combining CoQ10 with the MOTS-c mitochondrial peptide: mechanism overlap, pharmacodynamic interactions, statin considerations, and practical dosing protocols.
Evidence-based guide on combining ginseng with MOTS-c mitochondrial peptide. Covers pharmacodynamic overlap on glucose and AMPK pathways, anticoagulant potentiation, dose-separation strategies, and monitoring recommendations.
Evidence-based guide to combining glycine supplementation with MOTS-c mitochondrial peptide, covering pharmacokinetic and pharmacodynamic interactions, dose-separation timing, glycemic effects, and clinical monitoring.
Evidence-based guide on combining green tea extract or EGCG with the MOTS-c mitochondrial peptide. Covers interaction mechanisms, dose-separation strategies, hepatotoxicity risk, and monitoring recommendations.
A guide on combining L-theanine with the MOTS-c mitochondrial peptide: mechanisms, pharmacokinetics, safety evidence, dosing windows, and monitoring recommendations.
A guide to combining melatonin with MOTS-c peptide: mechanism overlap, pharmacodynamic interactions, dosing windows, glucose monitoring, and safety evidence.
A thorough clinical review of combining N-acetylcysteine (NAC) with the mitochondrial peptide MOTS-c, covering mechanisms, potential pharmacodynamic interactions, dosing timing, and monitoring guidance.
MOTS-c and quercetin share overlapping AMPK and mitochondrial pathways. Learn whether combining them is safe, how quercetin's CYP3A4 inhibition may affect peptide metabolism, and what monitoring to request from your prescriber.
A guide to combining reishi mushroom with MOTS-c peptide: pharmacodynamic interactions, immune and coagulation considerations, dosing windows, monitoring parameters, and when to avoid the combination entirely.
A breakdown of combining MOTS-c mitochondrial peptide with resveratrol: shared pathways, potential interactions, dosing windows, and safety monitoring.
A guide to combining saw palmetto with MOTS-c peptide therapy, covering mechanisms, pharmacodynamic interactions, dosing timing, and safety monitoring.
Expert analysis of the MOTS-c and St. John's Wort interaction, covering CYP3A4 induction, pharmacokinetic concerns, dose-separation strategies, and monitoring recommendations.
A clinical review of combining MOTS-c mitochondrial peptide with turmeric or curcumin supplements, covering pharmacodynamic interactions, anti-inflammatory overlap, mild anticoagulant risk, and practical dosing guidance.
Evidence-based guide on combining vitamin B12 with MOTS-c mitochondrial peptide. Covers interaction mechanisms, dose-separation windows, monitoring protocols, and safety considerations.
A guide covering whether vitamin B6 is safe to take with MOTS-c peptide, how they interact mechanistically, what doses matter, and what monitoring looks like in practice.
Evidence-based guide to taking zinc alongside the mitochondrial peptide MOTS-c. Covers pharmacokinetic and pharmacodynamic interactions, dose-separation windows, testosterone pathway effects, copper balance risks, and monitoring recommendations.
Folate and MOTS-c evidence separating cell-model one-carbon metabolism, clinical interaction data, MTHFR myths, and established folate guidance.
A source-led review of MOTS-c with creatine, separating creatine kidney-marker evidence from the missing administered-human MOTS-c interaction data.
Explore how MOTS-c signaling differs from glutathione biology and why laboratory findings do not establish a combined injection protocol or recovery benefit.
A source-led review of MOTS-c with magnesium, separating established magnesium evidence from the missing administered-human MOTS-c interaction data.